Desperately Seeking Serotonin... A Commentary on the Withdrawal of Tegaserod and the State of Drug Development for Functional and Motility Disorders

Gastroenterology

Volumn 132, Issue 7, 2007, Pages 2287-2290

  Pasricha, Pankaj Jay ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 5 CHLORO N (8 METHYL 8 AZABICYCLO[3.2.1]OCT 3ALPHA YL) 2 (1 METHYL 2 BUTYNYLOXY)BENZAMIDE; AGN 203818; ALOSETRON; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ASIMADOLINE; AV 608; AZD 7371; BMS 562086; CILANSETRON; CROFELEMER; DDP 225; DDP 733; DNK 333; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GTP 010; GW 876008; NEPADUTANT; NEUROKININ; PROBIOTIC AGENT; RAMOSETRON; RENZAPRIDE; ROFECOXIB; SAREDUTANT; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 3 ANTAGONIST; SOLABEGRON; SSR 241586; TALNETANT; TEGASEROD; TIANEPTINE; TZP 101; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; DRUG MECHANISM; DRUG SAFETY; DYSPEPSIA; GASTROINTESTINAL MOTILITY DISORDER; HEART MUSCLE ISCHEMIA; HUMAN; IRRITABLE COLON; ISCHEMIC COLITIS; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; STOMACH PARESIS;

EID: 34250007918     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.04.057     Document Type: Article

References (13)

1. Morganroth J., Ruegg P.C., Dunger-Baldauf C., Appel-Dingemanse S., Bliesath H., and Lefkowitz M. Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects. Am J Gastroenterol 97 (2002) 2321-2327
2. Novartis. Data on File. Personal Communication.
3. Horwitz B.J., and Fisher R.S. The irritable bowel syndrome. N Engl J Med 344 (2001) 1846-1850
4. Ashburn T.T., and Gupta M.S. The IBS market. Nat Rev Drug Discov 5 (2006) 99-100
5. Geeraerts B., van Oudenhove L., and Tack J. Serotonin transporter gene polymorphisms in irritable bowel syndrome. Neurogastroenterol Motil 18 (2006) 957-959
6. Mayer E.A., and Collins S.M. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 122 (2002) 2032-2048
7. Winston J., Shenoy M., Medley D., Naniwadekar A., and Pasricha P.J. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 132 (2007) 615-627
8. Jones III R.C., Xu L., and Gebhart G.F. The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci 25 (2005) 10981-10989
9. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288 (2000) 306-313
10. Gershon M.D., and Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132 (2007) 397-414
11. Mawe G.M., Coates M.D., and Moses P.L. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther 23 (2006) 1067-1076
12. Andresen V., and Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs 66 (2006) 1073-1088
13. Mayer E.A., Tillisch K., and Bradesi S. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 24 (2006) 919-933